hello all time for some light fun :d stonks only go up- this one must have 200x upside! welcome to the infinite liquidity basket :D
Indaptus Therapeutics Inc (NASDAQ:INDP) Over 25% of INDP's tradable shares are in the hands of short sellers, meaning they sold the stock and are holding for further declines. Unlike buying a stock, when you can only lose as much as you invest, a short seller's loss potential is unlimited, which is one of the reasons why short squeezes occur, specifically in...
Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy.
Indaptus Therapeutics Inc (NASDAQ:INDP) The company's 13D filing on Friday after hours showed that Michael J. Newman had reported a stake of 25.7% in the company. The filing came out later in the session, so I think the stock should see a nice bump when it opens for trade on Monday. With such a low float and an oversold chart, this could create an explosive...